Considering the many studies showing the beneficial effects of IFN-γ in response to ICIs, the importance of IFN-γ itself and IFN-γ-related gene signatures (IFN-γ scores) as biomarkers or predictors of the clinical outcome of melanoma patients treated with ICIs has been extensively considered [71–73]. Here, IFNG is linked to melanoma.